HAGENS BERMAN, NATIONAL TRIAL ATTOREYS, Encourages Novavax (NVAX) Investors with Significant Losses to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO: SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ -- Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/NVAX Contact An Attorney Now: NVAX@hbsslaw.com 844-916-0895 Novavax, Inc. (NVAX) Investigation: The U.S. government invested approximately $1.6 billion in Novavax in 2020 in the...

Click to view original post